...
首页> 外文期刊>The Journal of Urology >Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction
【24h】

Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction

机译:前列腺切除术后勃起功能障碍的长期满意度和体内注射的预测指标

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Intracorporeal injections have low use rates and high discontinuation rates. We examined factors associated with intracorporeal injection use, long-term satisfaction with intracorporeal injection and reasons for discontinuation in men treated with radical prostatectomy. Materials and Methods: Between October 2000 and September 2003, 731 men who underwent open radical retropubic prostatectomy were enrolled in a prospective outcomes study. The 8-year followup evaluation included the UCLA-PCI, and a survey capturing intracorporeal injection use, satisfaction and reasons for discontinuation. Logistic regression was used to determine associations between intracorporeal injection use and preoperative variables. Results: The 8-year self-assessment was completed by 368 (50.4%) men. Of these men 140 (38%) indicated prior or current intracorporeal injection use, with only 34 using intracorporeal injection at 8 years. Overall, 44% of the men were satisfied with intracorporeal injections. Reasons for discontinuation included dislike (47%), pain (33%), return of erection (19%), inefficacy (14%) and no partner (6%). Men trying intracorporeal injections had greater preoperative UCLA-PCI sexual function scores (75.2 vs 65.62, p = 0.00005) as well as greater decreases in this score at 3 months (p = 0.0002) and 2 years (p = 0.003). Higher preoperative sexual function scores were independently associated with the use of intracorporeal injections in a model adjusted for age, marital status, nerve sparing status and body mass index (OR 1.021, 95% CI 1.008-1.035). Conclusions: Men pursuing intracorporeal injections have better baseline erectile function and experience greater deterioration in erectile function during the early postoperative period. Despite the high efficacy of injections, many men discontinue intracorporeal injections due to dislike or discomfort. Satisfaction rates for intracorporeal injections indicate their long-term role in restoring sexual function in men with post-prostatectomy erectile dysfunction. ? 2013 American Urological Association Education and Research, Inc.
机译:目的:体内注射使用率低,停药率高。我们检查了与体内注射使用相关的因素,对体内注射的长期满意程度以及接受前列腺癌根治术的男性停药的原因。材料和方法:在2000年10月至2003年9月之间,对731例行了根治性耻骨后前列腺切除术的男性进行了一项前瞻性研究。为期8年的随访评估包括UCLA-PCI,以及一项收集体内注射使用,满意度和停药原因的调查。 Logistic回归用于确定体内注射使用与术前变量之间的关联。结果:368名(50.4%)男性完成了为期8年的自我评估。在这些男性中,有140名(38%)表示曾使用过或目前已经进行过体内注射,只有34名在8岁时使用了体内注射。总体而言,有44%的男性对体内注射感到满意。停药的原因包括不喜欢(47%),疼痛(33%),勃起恢复(19%),无效(14%)和没有伴侣(6%)。尝试进行体内注射的男性术前UCLA-PCI性功能评分更高(75.2 vs 65.62,p = 0.00005),并且在3个月(p = 0.0002)和2年(p = 0.003)时,该评分的下降幅度更大。在针对年龄,婚姻状况,神经保护状况和体重指数进行调整的模型中,术前较高的性功能评分与体内注射的使用独立相关(OR 1.021,95%CI 1.008-1.035)。结论:进行体内注射的男性在术后早期具有更好的基线勃起功能,勃起功能恶化更大。尽管注射的功效很高,但许多男性由于不喜欢或不舒服而中断了体内注射。体内注射的满意率表明,它们在前列腺切除术后勃起功能障碍的男性中恢复性功能的长期作用。 ? 2013美国泌尿科协会教育与研究公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号